SCHEMBL10047324

SCHEMBL10047324

O=S(=O)(N=Cc1ccc(Cl)cc1)c1ccc(Br)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
POLB P06746 1/20 0.48
CA1 P00915 3/20 0.46
CA2 P00918 3/20 0.46
CA9 Q16790 3/20 0.46
CA12 O43570 1/20 0.46
KMT2A Q03164 3/20 0.45
MEN1 O00255 2/20 0.44
MAOB P27338 1/20 0.44
F2 P00734 4/20 0.42
PRSS1 P07477 4/20 0.42
PRSS2 P07478 4/20 0.42
PRSS3 P35030 4/20 0.42
MAPT P10636 2/20 0.41
GFER P55789 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA4 P22748 2/20 0.40
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12444227 1.00 ALDH1A1 (0.48) ALDH1A1POLBCA1CA2CA9
SCHEMBL23776044 1.00 ALDH1A1 (0.48) ALDH1A1POLBCA1CA2CA9
SCHEMBL8956925 0.91 ALDH1A1 (0.54) ALDH1A1POLBCA1CA2CA9
SCHEMBL8956933 0.91 ALDH1A1 (0.54) ALDH1A1POLBCA1CA2CA9
SCHEMBL15975334 0.83 ALDH1A1 (0.48) ALDH1A1POLBCA1CA2CA9
SCHEMBL10047339 0.83 ALDH1A1 (0.68) ALDH1A1POLBCA2CA9CA12
SCHEMBL10073978 0.83 ALDH1A1 (0.48) ALDH1A1POLBCA1CA2CA9
SCHEMBL10047332 0.83 ALDH1A1 (0.68) ALDH1A1POLBCA1CA2CA9
SCHEMBL12444230 0.83 ALDH1A1 (0.68) ALDH1A1POLBCA2CA9CA12
SCHEMBL12444212 0.83 ALDH1A1 (0.68) ALDH1A1POLBCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB ALDH1A1 1074/4885POLB 2318/4885CA1 4521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.